12th Berlin Conference on Life Sciences 2019

The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and governmental institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

What you can expect:

  • 350+ attendees from 20+ countries
  • 70+ high-level speakers discussing current AMR issues
  • Focus on humans and animals
  • Financing and funding | Start-up pitch | Clinical Development and market access | Therapeutics and diagnostics | R&D trends
  • Policy forum, supported by WHO and UNCTAD
  • Pre-conference workshop on ‘Resistance Testing’
  • Poster session, exhibition and pre-scheduled one-to-one investor meetings


I commenti sono chiusi.